News

News Subscription

Jun 23. 2020
Basilea enters into sale and leaseback agreement for corporate headquarters building
Read more
Download
Jun 22. 2020
Basilea receives CHF 5 million milestone payment related to marketing authorization of antifungal Cresemba® in Russia
Read more
Download
May 28. 2020
Basilea provides corporate update
Read more
Download
Apr 29. 2020
Basilea announces appointment of new Head of Global Quality Management
Read more
Download
Apr 08. 2020
Basilea shareholders approve all proposals of the Board of Directors at the Annual General Meeting
Read more
Download
Feb 27. 2020
Basilea reports the launch of antifungal Cresemba® (isavuconazole) in Australia triggering the first milestone payment related to Asia-Pacific
Read more
Download
Feb 18. 2020
Basilea reports significant revenue growth from marketed products and pipeline progress for full-year 2019
Read more
Download
Jan 23. 2020
Basilea reports activity of derazantinib in preclinical models of gastric cancer at ASCO Gastrointestinal Cancers Symposium
Read more
Download
Jan 22. 2020
Basilea announces clinical supply agreement for its planned study FIDES-03 with derazantinib in gastric cancer
Read more
Download
Jan 10. 2020
Basilea reports total revenue exceeding guidance driven by higher than expected contributions from Cresemba® and Zevtera® in 2019
Read more
Download